Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)

NCT00817024 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules,
DRUG: Sheng Mai Capsules Plus Placebo of Xuefu Zhuyu Capsules
DRUG: Placebo of Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules

Sponsor

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Collaborators

[object Object]